Development, screening, and analysis of DNA aptamer libraries potentially useful for diagnosis and passive immunity of arboviruses

BMC Research Notes

John S Lee²  Carrie Andrews¹  Taylor Phillips¹  Alicia M Richarte¹  Maria P Carrillo¹  John G Bruno¹ 

[1]Operational Technologies Corporation, 4100 NW Loop 410, Suite 230, San Antonio, TX, 78229, USA

[2]U.S. Army Medical Research and Materiel Command, Military Infectious Disease Research Program, 504 Scott Street, Bldg. 722, Fort Detrick, MD, 21702, USA

关键词: SELEX;    Lateral flow;    Fluorescence;    Enzyme-linked;    DNA;    Consensus;    Arbovirus;    Aptamer;   

Others  :  1165225
DOI  :  10.1186/1756-0500-5-633

 received in 2012-05-18, accepted in 2012-11-07,  发布年份 2012

【 摘 要 】

Background

Nucleic acid aptamers have long demonstrated the capacity to bind viral envelope proteins and to inhibit the progression of pathogenic virus infections. Here we report on initial efforts to develop and screen DNA aptamers against recombinant envelope proteins or synthetic peptides and whole inactivated viruses from several virulent arboviruses including Chikungunya, Crimean-Congo hemorrhagic fever (CCHF), dengue, tickborne encephalitis and West Nile viruses. We also analyzed sequence data and secondary structures for commonalities that might reveal consensus binding sites among the various aptamers. Some of the highest affinity and most specific aptamers in the down-selected libraries were demonstrated to have diagnostic utility in lateral flow chromatographic assays and in a fluorescent aptamer-magnetic bead sandwich assay. Some of the reported aptamers may also be able to bind viral envelope proteins in vivo and therefore may have antiviral potential in passive immunity or prophylactic applications.

Results

Several arbovirus DNA aptamer sequences emerged multiple times in the various down selected aptamer libraries thereby suggesting some consensus sequences for binding arbovirus envelope proteins. Screening of aptamers by enzyme-linked aptamer sorbent assay (ELASA) was useful for ranking relative aptamer affinities against their cognate viral targets. Additional study of the aptamer sequences and secondary structures of top-ranked anti-arboviral aptamers suggest potential virus binding motifs exist within some of the key aptamers and are highlighted in the supplemental figures for this article. One sequence segment (ACGGGTCCGGACA) emerged 60 times in the anti-CCHF aptamer library, but nowhere else in the anti-arbovirus library and only a few other times in a larger library of aptamers known to bind bacteria and rickettsia or other targets. Diagnostic utility of some of the aptamers for arbovirus detection in lateral flow chromatographic assays and a fluorescent sandwich assay on the surface of magnetic microbeads is also demonstrated.

Conclusions

This article catalogues numerous DNA aptamer sequences which can bind various important pathogenic arboviruses and have, in some cases, already demonstrated diagnostic potential. These aptamer sequences are proprietary, patent-pending, and partially characterized. Therefore, they are offered to the scientific community for potential research use in diagnostic assays, biosensor applications or for possible passive immunity and prophylaxis against pathogenic viruses.

【 授权许可】

   
2012 Bruno et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Bruno JG, Kiel JL: Use of magnetic beads in selection and detection of biotoxin aptamers by ECL and enzymatic methods. Biotechniques 2002, 32:178-182.
• [2]Bruno JG, Carrillo MP, Phillips T, Edge A: Discrimination of recombinant from natural human growth hormone using DNA aptamers. J Biomolec Techn 2011, 22:27-36.
• [3]Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R: A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem 2004, 279:48410-48419.
• [4]Cheng C, Dong J, Yao L, Chen A, Jia R, Huan L, Guo J, Shu Y, Zhang Z: Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem Biophys Res Comm 2009, 366:670-674.
• [5]Park SY, Kim S, Yoon H, Kim KB, Kalme SS, Oh S, Song CS, Kim DE: Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus. Nucleic Acid Ther 2011, 21:395-402.
• [6]Kikuchi K, Umehara T, Nishikawa F, Fukuda K, Hasegawa T, Nishikawa S: Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Biochem Biophys Res Comm 2009, 386:118-123.
• [7]Ellenbecker M, Sears L, Li P, Lanchy JM, Stephen Lodmell J: Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. Antiviral Res 2012, 93:330-339.
• [8]Dey AK, Griffiths C, Lea SM, James W: Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. RNA 2005, 11:873-884.
• [9]Healy JM, Lewis SD, Kurz M, Boomer RM, Thompson KM, Wilson C, McCauley TG: Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm Res 2004, 21:2234-2246.
• [10]Pendergrast PS, Marsh HN, Grate D, Healy JM, Stanton M: Nucleic acid aptamers for target validation and therapeutic applications. J Biomolec Techn 2005, 16:224-234.
• [11]Chahar HS, Bharaj P, Dar L, Guleria R, Kabra SK, Broor S: Co-infections with Chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis 2009, 15:1077-1080.
• [12]Niedrig M, Zeller H, Schuffenecker I, Drosten C, Emmerich P, Rumer L, Donoso-Mantke O: International diagnostic accuracy study for the serological detection of Chikungunya virus infection. Clin Microbiol Infect 2009, 15:880-884.
• [13]Santhosh SR, Dash PK, Parida M, Khan M, Rao PV: Appearance of E1:A226V mutant Chikungunya virus in coastal Karnataka, India during 2008 outbreak. Virology J 2009, 6:172-178. BioMed Central Full Text
• [14]Whitehouse CA: Crimean-Congo Hemorrhagic Fever. Antiviral Res 2004, 64:145-160.
• [15]Ahmed AA, McFalls JM, Hoffmann C, Filone CM, Stewart SM, Paragas J, Khodjaev S, Shermukhamedova D, Schmaljohn CS, Doms RW, Bertolotti-Ciarlet A: Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo Hemorrhagic Fever virus. J Gen Virol 2005, 86:3327-3336.
• [16]Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS, Doms RW: Identification of a novel C-terminal cleavage of Crimean-Congo Hemorrhagic Fever virus PreGN that leads to generation of an NSM protein. J Virol 2007, 81:6632-6642.
• [17]Pletnev AG, Yamshchikov VF, Blinov VM: Tick-borne encephalitis virus genome: the nucleotide sequence coding for virion structural proteins. FEBS Lett 1986, 200:317-321.
• [18]Craig SC, Pittman PR, Lewis TE, Rossi CA, Henchal EA, Kuschner RA, Martinez C, Kohlhase KF, Cuthie JC, Welch GE, Sanchez JL: An accelerated schedule for tick-borne encephalitis vaccine: the American military experience in Bosnia. Am J Trop Med Hyg 1999, 61:874-878.
• [19]Weaver SC, Reisen WK: Present and future arboviral threats. Antiviral Res 2010, 85:328-345.
• [20]Chang GJ, Kuno G, Purdy DE, Davis BS: Recent advancement in flavivirus vaccine development. Expet Rev Vaccine 2004, 3:199-220.
• [21]Coller BA, Clements DE, Martyak T, Yelmene M, Thorne M, Parks DE: Advances in flavivirus vaccine development. IDrugs 2010, 13:880-884.
• [22]Ray D, Shi PY: Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Pat Anti-infect Drug Discov 2006, 1:45-55.
• [23]Pulmanausahakul R, Khakpoor A, Smith DR: The development of flavivirus vaccines. African J Biotechnol 2010, 9:409-415.
• [24]Liu J, Mazumdar D, Lu Y: A simple and sensitive “dipstick” test in serum based on lateral flow separation of aptamer-linked nanostructures. Ang Chem Int Ed 2006, 45:1-5.
• [25]Xu H, Mao X, Zeng Q, Wang S, Kawde AN, Liu G: Aptamer-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for protein analysis. Anal Chem 2009, 81:669-675.
• [26]Hofacker IL: Vienna RNA secondary structure server. Nucleic Acids Res 2003, 31:3429-3431.
• [27]Cowperthwaite MC, Ellington AD: Bioinformatic analysis of the contribution of primer sequences to aptamer structures. J Mol Evol 2008, 67:95-102.
• [28]Bruno JG, Carrillo MP, Phillips T, Hanson D, Bohmann JA: DNA aptamer beacon assay for C-telopeptide and handheld fluorometer to monitor bone resorption. J Fluoresc 2011, 21:2021-2033.
• [29]Bruno JG, Carrillo MP, Phillips T, Vail NK, Hanson D: Competitive FRET-aptamer-based detection of methylphosphonic acid: a common nerve agent metabolite. J Fluoresc 2008, 18:867-876.
• [30]Bruno JG, Francis K, Ikanovic M, Rao P, Dwarakanath S, Rudzinski W: Reovirus detection using immunomagnetic-fluorescent nanoparticle sandwich assays. J Bionanosci 2007, 1:84-89.